Showing results (111-120 of 464) with videos related to

Sort By:
Pageof 47
Blood|April 1, 1988
Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipientsH J Deeg, J Aprile, R Storb, et al.
Cancer|July 15, 1994
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed diseaseT Demirer, C D Buckner, K Lilleby, et al.
Experimental Hematology|December 1, 1987
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemiaF R Appelbaum, J Barrall, R Storb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
The detection of bone marrow involvement by lymphoma using magnetic resonance imagingA F Shields, B A Porter, S Churchley, et al.
Bone Marrow Transplantation|November 18, 2000
Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantationS Koc, H Hagglund, R C Ireton, et al.
Transplantation|December 1, 1991
Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor bloodM A Bean, R Storb, T Graham, et al.
Leukemia|December 1, 1996
Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studiesT Tsai, S Davalath, C Rankin, et al.
Bone Marrow Transplantation|January 1, 1990
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipientsW C Ladiges, R Storb, R F Raff, et al.
Blood|January 13, 1999
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant modelsD C Matthews, P J Martin, C Nourigat, et al.
British Journal of Haematology|September 1, 1993
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemiaK Doney, R Storb, F R Appelbaum, et al.
Pageof 47